Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-03-03

Clinical Trial Update: Efficacy of Ecabet Sodium and Proton Pump Inhibitor Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection [Phase 4]

View source ↗

Summary

Phase 4 study evaluating whether combining ecabet sodium with a proton pump inhibitor improves healing of iatrogenic gastric ulcers after endoscopic submucosal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ecabet sodium (ecabet sodium)
  • Proton Pump Inhibitor (proton pump inhibitor)

Snippet

Sponsor: Samsung Medical Center | Conditions: Delayed Bleeding,, Healing Ulcer | Phase 4 | Status: UNKNOWN